Who
Stephen T. Wills
Executive VP and CFO/COO
Company insider
Files Form 4 as: Executive VP and CFO/COO, Palatin Technologies; Director, Gamida Cell; Director, Derma Sciences; Director, U.S. Helicopter.
In numbers
- Trades disclosed
- 268
- Buys
- 11
- Sells
- 5
- Bought
- $225.2M
- Sold
- $126K
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 30 Dec 2005
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $25922 at $11.77 | filing |
| 15 Jul 2026filed 17 Jul 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $92679 at $11.72 | filing |
| 15 Jul 2026filed 17 Jul 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $1,34894 at $14.34 | filing |
| 15 Jul 2026filed 17 Jul 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $25922 at $11.77 | filing |
| 15 Jul 2026filed 17 Jul 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $92679 at $11.72 | filing |
| 15 Jul 2026filed 17 Jul 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $1,34894 at $14.34 | filing |
| 30 Dec 2025filed 2 Jan 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $55626 at $21.38 | filing |
| 30 Dec 2025filed 2 Jan 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $1,94691 at $21.38 | filing |
| 30 Dec 2025filed 2 Jan 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $2,03195 at $21.38 | filing |
| 30 Dec 2025filed 2 Jan 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $55626 at $21.38 | filing |
| 30 Dec 2025filed 2 Jan 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $1,94691 at $21.38 | filing |
| 30 Dec 2025filed 2 Jan 2026 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $2,03195 at $21.38 | filing |
| 24 Dec 2025filed 29 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Sold | $9,458565 at $16.74 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —142 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —518 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —495 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —95 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —330 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code A | —345 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | PTN Palatin TechnologiesBiotechnology | SEC FORM 4 Code F | $26433 at $8.00 | filing |
News
Palatin Technologies (OTCMKTS:PTNT) Share Price Breaks Above Two Hundred Day Moving Average – What's Next?PTN · dailypolitical.com · 9 Oct 2026
0 headlines in the last 90 days name Stephen T. Wills; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.